Codexis (CDXS) EBT Margin (QoQ) (2010 - 2026)
Codexis (CDXS) EBT Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.71 Bn | 130.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.60 Bn | 77.60 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.82 Bn | 59.63 Bn | 1.37 Bn |
| 4 | Moderna | 57.92 Bn | 52.79 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.88 Bn | 36.78 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.46 Bn | 28.15 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.96 Bn | 9.57 Bn | 668.28 Mn |
| 8 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Codexis | 151.60 Mn | 96.69 Mn | 11.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,358.00 |
| Mar 31, 2026 | -8,156.00 |
| Dec 31, 2025 | 25,268.00 |
| Sep 30, 2025 | -14,144.00 |
| Jun 30, 2025 | 18,760.00 |
| Mar 31, 2025 | -22,579.00 |
| Dec 31, 2024 | 11,242.00 |
| Sep 30, 2024 | 12,430.00 |
| Jun 30, 2024 | -21,773.00 |
| Mar 31, 2024 | 7,581.00 |
| Dec 31, 2023 | 23,305.00 |
| Sep 30, 2023 | -14,591.00 |
| Jun 30, 2023 | -5,619.00 |
| Mar 31, 2023 | -11,120.00 |
| Dec 31, 2022 | -3,393.00 |
| Sep 30, 2022 | -2,237.00 |
| Jun 30, 2022 | 1,703.00 |
| Mar 31, 2022 | 1,769.00 |
| Dec 31, 2021 | -4,771.00 |
| Sep 30, 2021 | 2,313.00 |